Impact of quality of life to overall productivity impairment and activity impairment of patients with systemic lupus erythematosus

Impact of quality of life to overall productivity impairment and activity impairment of patients with systemic lupus erythematosus - PEONY study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030210647

Enrollment

207

Registered

2022-03-06

Start date

2022-03-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus -

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with informed consent 2. Patients with Age >= 18 years old 3. Patients diagnosed with SLE >= 16 years old 4. Patients diagnosed as systemic lupus erythematosus according to the revised 1997 American College of Rheumatology (ACR) or SLICC criteria.

Exclusion criteria

Exclusion criteria: 1. Patients with a diagnosis of SLE within 12 months. 2. Patients who are judged to need hospitalization when unscheduled visit. 3. Patient who, in the opinion of the investigator, is unlikely to comply with the protocol or is unsuitable for any other reason.

Design outcomes

Primary

Measure	Time frame
Assess the residual burden remaining after meet LLDAS.	—

Secondary

Measure	Time frame
Relationship between Activity Impairment and PROs in 2 groups (non LLDAS/LLDAS).	—

Contacts

Public ContactMitsuru Hoshino

AstraZeneca K.K.

mitsuru.hoshino@astrazeneca.com+81-6-4802-3600

Outcome results